Related Experiment Video
Updated: Oct 14, 2025
08:09
Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
Published on: March 24, 2017
9.7K
Identifying Epstein-Barr virus peptide sequences associated with differential IgG antibody response
Anna E Coghill1, Jianwen Fang2, Zhiwei Liu3
1Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA; Cancer Epidemiology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
Summary
Researchers identified key Epstein-Barr virus (EBV) peptide sequences involved in human B-cell immunity by analyzing immunoglobulin G (IgG) antibody responses in healthy adults. This study advances understanding of EBV-directed humoral immunity.
Area of Science:
- Immunology
- Virology
- Cancer Research
Background:
- Epstein-Barr virus (EBV) is linked to cancers in some infected individuals.
- Understanding variations in EBV-directed humoral immunity in healthy adults is crucial.
- Humoral immunity plays a role in the immune response to EBV infection.
Purpose of the Study:
- To identify specific Epstein-Barr virus (EBV) peptide sequences that elicit immunoglobulin G (IgG) antibody responses in cancer-free adults.
- To explore variations in EBV-directed humoral immunity.
- To pinpoint immunodominant regions of EBV proteins relevant for B-cell immunity.
Main Methods:
- Utilized a protein microarray to analyze serum from 316 healthy adults (175 Taiwanese, 141 Northern European).
- Probed for immunoglobulin G (IgG) antibody responses against 115 peptide sequences from 45 EBV proteins.
- Employed an antibody-based approach to identify immunogenic EBV peptide sequences.
Main Results:
- Identified eight EBV peptide sequences associated with immunogenicity.
- Three proteins (BALF5, LMP1, LMP2A) showed IgG reactivity with specific segments/regions.
- Five proteins (BDLF4, EBNA3A, EBNA3B, EBNA-LP, LF1) demonstrated IgG reactivity linked to sequence variants.
Conclusions:
- This study is a significant step in identifying specific EBV protein sequences involved in human B-cell immunity.
- The findings contribute to understanding the humoral immune response to EBV.
- Further research can build upon these identified immunogenic EBV peptide sequences.
